Advertisement

Topics

Infectious-diseases Reports

15:38 EST 14th November 2018 | BioPortfolio

Clostridium difficile Infections Clostridium difficile Associated Disease Pipeline Review, H2 2018 [Report Updated: 30102018] Prices from USD $2000

Clostridium difficile Infections Clostridium difficile Associated Disease Pipeline Review, H2 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Clostridium difficile Infections Pipeline Review, H2 2018, provides an overview of the Clostridium difficile Infections Infectious Disease pipeline landscape.Clostridium difficile infections are caused by Clos...

Global C Difficile Infection Drug Market Status and Outlook 20182025 [Report Updated: 16082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynamics Regulations and Global Market OverviewPart 2:Upstream Raw Materials / Components Manufacturing Procurement Methods Channels and Cost , Major Regional Production Overview and Trade FlowPart 3:Pr...

Measles Pipeline Review, H2 2018 [Report Updated: 16102018] Prices from USD $2000

Measles Pipeline Review, H2 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Measles Pipeline Review, H2 2018, provides an overview of the Measles Infectious Disease pipeline landscape.Measles is a highly infectious viral disease. The virus lives in the mucus of the nose and throat of people with this infection. Physical contact, coughing and sneezin...

2018 POC Infectious Disease Testing Market: Reagent and Instrument Supplier Shares, Sales Segment Forecasts for 100 Tests, Emerging Technologies, Instrumentation Review, Competitive Landscape, Opportunities for Suppliers [Report Updated: 01011970] Prices

VPGMarketResearchrsquo;s new report provides comprehensive analysis of thenbsp; POC infections disease testing market, including its dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. RationaleThe growing economic pressures on hospitals, coupled with advances in diagnostic technologies, i...

2018 Global Influenza Diagnostic Testing Market: US, Europe, JapanSupplier Shares, Volume and Sales Segment Forecasts, Competitive Analysis, Emerging Technologies, Instrumentation Review, Opportunities for Suppliers [Report Updated: 01011970] Prices from

The report presents a detailed analysis of the Influenza diagnostics market in the US, Europe, France, Germany, Italy, Spain, UK and Japan. Current scientific views on the Influenza definition, epidemiology and etiology are reviewed. The report provides the 5year test volume and sales forecasts by country for the following market segments:nbsp; nbsp; nbsp; Hospitalsnbsp; nbsp; nbsp; Commercial/Pri...

Global Clostridium Difficile Treatment Market Status and Outlook 20182025 [Report Updated: 16082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynamics Regulations and Global Market OverviewPart 2:Upstream Raw Materials / Components Manufacturing Procurement Methods Channels and Cost , Major Regional Production Overview and Trade FlowPart 3:Pr...

Chlamydia Infections Pipeline Review, H2 2018 [Report Updated: 26092018] Prices from USD $2000

Chlamydia Infections Pipeline Review, H2 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chlamydia Infections Pipeline Review, H2 2018, provides an overview of the Chlamydia Infections Infectious Disease pipeline landscape.Chlamydia is a sexually transmitted infection caused by a bacterium. Symptoms include burning feeling during urination, discharg...

Influenza A Virus, H5N1 Subtype Infections Pipeline Review, H2 2018 [Report Updated: 26092018] Prices from USD $2000

Influenza A Virus, H5N1 Subtype Infections Pipeline Review, H2 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Influenza A Virus, H5N1 Subtype Infections Pipeline Review, H2 2018, provides an overview of the Influenza A Virus, H5N1 Subtype Infections Infectious Disease pipeline landscape.H5N1 is a type of influenza virus that causes a highly infecti...

Influenza A Virus, H1N1 Subtype Infections Pipeline Review, H2 2018 [Report Updated: 26092018] Prices from USD $2000

Influenza A Virus, H1N1 Subtype Infections Pipeline Review, H2 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Influenza A Virus, H1N1 Subtype Infections Pipeline Review, H2 2018, provides an overview of the Influenza A Virus, H1N1 Subtype Infections Infectious Disease pipeline landscape.H1N1 Infection also called as swine flu is a new kind of flu i...

Cryptococcosis Pipeline Review, H2 2018 [Report Updated: 14082018] Prices from USD $2000

Cryptococcosis Pipeline Review, H2 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cryptococcosis Pipeline Review, H2 2018, provides an overview of the Cryptococcosis Infectious Disease pipeline landscape.Cryptococcosis is infection caused by Cryptococcus neoformans fungus. Symptoms include cough, fatigue, fever, head ache, nausea and skin rashes. P...

Global Influenza Vaccines Market, Persons Vaccinated, Brand Analysis, Size, Share, Growth, Trends, Major Deals Forecast to 2024 [Report Updated: 12072018] Prices from USD $1800

The global influenza vaccines market is anticipated to exceed US$ 5.8 Billion mark by 2024, and is presenting ample opportunities to the industry's players. Influenza viruses are considered as a major cause of morbidity and mortality worldwide. The vast population base together with significantly low vaccination coverage in emerging markets, introduction of new vaccines, rising government support ...

Osteomyelitis Pipeline Review, H2 2018 [Report Updated: 14082018] Prices from USD $2000

Osteomyelitis Pipeline Review, H2 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Osteomyelitis Pipeline Review, H2 2018, provides an overview of the Osteomyelitis Infectious Disease pipeline landscape.Osteomyelitis is an infection in a bone. Infections can reach a bone by traveling through the bloodstream or spreading from nearby tissue. Symptoms i...

Influenza A Virus, H3N2 Subtype Infections Pipeline Review, H2 2018 [Report Updated: 14082018] Prices from USD $2000

Influenza A Virus, H3N2 Subtype Infections Pipeline Review, H2 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Influenza A Virus, H3N2 Subtype Infections Pipeline Review, H2 2018, provides an overview of the Influenza A Virus, H3N2 Subtype Infections Infectious Disease pipeline landscape.H3N2 infections are caused by variant H3N2 virus which is an i...

DNA Gyrase Subunit B EC 5.99.1.3 Pipeline Review, H2 2018 [Report Updated: 21082018] Prices from USD $3500

DNA Gyrase Subunit B EC 5.99.1.3 Pipeline Review, H2 2018SummaryDNA Gyrase Subunit B EC 5.99.1.3 pipeline Target constitutes close to 6 molecules. The latest report DNA Gyrase Subunit B EC 5.99.1.3 Pipeline Review, H2 2018, outlays comprehensive information on the DNA Gyrase Subunit B EC 5.99.1.3 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of act...

Candidiasis Pipeline Review, H2 2018 [Report Updated: 14082018] Prices from USD $2000

Candidiasis Pipeline Review, H2 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Candidiasis Pipeline Review, H2 2018, provides an overview of the Candidiasis Infectious Disease pipeline landscape.Candidiasis is caused by infection with species of the genus Candida, predominantly with Candida albicans. A Candida infection of the skin appears as a cle...

Quidel: USA, Europe, JapanSales, Market Shares and Competitive Position by Product [Report Updated: 01011970] Prices from USD $950

This unique market intelligence report from VPGMarketResearch provides information not available from any other published source. The report includes diagnostics sales and market share estimates by product and country for Quidel and its main competitors, as well as a profile of the companyrsquo;s diagnostics business. List of Tables Infectious Disease Testing Marketnbsp; Quidel US Helicobacter Pyl...

Assembly Biosciences Inc ASMB Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27082018] Prices from USD $250

SummaryAssembly Biosciences Inc Assembly, formerly Ventrus Biosciences Inc is a biotechnology company that develops, discovers, and commercializes small molecule therapies. The company develops therapies for the treatment of infectious diseases such as microbiotic therapies for Clostridium difficile C. difficile infections CDI and chronic hepatitis B virus HBV. It also develops Gemicel platform te...

Assembly Biosciences Inc ASMB Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12042018] Prices from USD $250

SummaryAssembly Biosciences Inc Assembly, formerly Ventrus Biosciences Inc is a biotechnology company that discover, develops and commercializes small molecule therapies. The company develops therapies for the treatment of infectious diseases such as chronic hepatitis B virus HBV and microbiotic therapies for Clostridium difficile C. difficile infections CDI. It also develops Gemicel platform tech...

Point of Care Molecular Diagnostics Market by Product Service Assays, Kits, Analyzers, Software, Application Respiratory Disease, Hospital Acquired Infection, Technology RTPCR, INAAT, End User Physician Office, ICUS Global Forecast to 2023 [Report Updat

The global POC molecular diagnostics market is projected to grow at a CAGR of 14.7%.The global point of care POC molecular diagnostics market is expected to reach USD 1440.2 million by 2023 from USD 725.5 million in 2018, at a CAGR of 14.7%. Growth in the POC molecular diagnostics market is driven by the increasing prevalence of infectious diseases, rising focus on decentralized diagnostics, and t...

Infectious Disease Diagnostics Market by Product Service Assay, Kit Reagent, Instruments, Disease Type Hepatitis, HIV, HAI, HPV, TB, Influenza, Technology Immunodiagnostics, PCR, NGS, End User Hospital, Research Institute Global Forecast to 2022 [Repor

The global infectious disease diagnostics market is projected to grow at a CAGR of 5.6%.The global infectious disease diagnostics market is expected to reach USD 19.35 billion by 2022 from USD 14.73 billion in 2017, at a CAGR of 5.6%. Growth in this market can primarily be attributed to factors such as increasing global prevalence of infectious diseases, shift in focus from centralized laboratorie...

Measles Pipeline Review, H1 2018 [Report Updated: 17042018] Prices from USD $2000

Measles Pipeline Review, H1 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Measles Pipeline Review, H1 2018, provides an overview of the Measles Infectious Disease pipeline landscape.Measles is a highly infectious viral disease. The virus lives in the mucus of the nose and throat of people with this infection. Physical contact, coughing and sneezin...

VancomycinResistant Enterococcus faecium Infections Pipeline Review, H1 2018 [Report Updated: 08052018] Prices from USD $2000

VancomycinResistant Enterococcus faecium Infections Pipeline Review, H1 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide VancomycinResistant Enterococcus faecium Infections Pipeline Review, H1 2018, provides an overview of the VancomycinResistant Enterococcus faecium Infections Infectious Disease pipeline landscape.Pathogenic strains of Enterococcus ...

Influenza A Virus, H7N9 Subtype Infections Pipeline Review, H1 2018 [Report Updated: 29062018] Prices from USD $2000

Influenza A Virus, H7N9 Subtype Infections Pipeline Review, H1 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Influenza A Virus, H7N9 Subtype Infections Pipeline Review, H1 2018, provides an overview of the Influenza A Virus, H7N9 Subtype Infections Infectious Disease pipeline landscape.Avian influenza A H7N9 is a subtype of influenza viruses. This...

BioDiem Ltd Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 16042018] Prices from USD $250

SummaryBioDiem Ltd BioDiem is a biotechnology company that focuses on developing and commercializing vaccines and infectious disease therapies. It develops vaccines and novel therapeutic candidates for the treatment of seasonal and pandemic influenza, antimicrobial and antifungal, and retinal disease. The company's product portfolio includes Live Attenuated Influenza Virus LAIV vaccine technology,...

Klebsiella pneumoniae Infections Pipeline Review, H1 2018 [Report Updated: 17042018] Prices from USD $2000

Klebsiella pneumoniae Infections Pipeline Review, H1 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Klebsiella pneumoniae Infections Pipeline Review, H1 2018, provides an overview of the Klebsiella pneumoniae Infections Infectious Disease pipeline landscape.Klebsiella pneumoniae is a Gramnegative bacteria. A Klebsiella pneumoniae infection is cause...

Advertisement
Quick Search
Advertisement
Advertisement

 

review and buy Infectious-diseases market research data and corporate reports here